CompletedNot Applicable

Tumor Registry of Advanced Renal Cell Carcinoma

Germany1,500 participantsStarted 2007-12

Plain-language summary

The purpose of this registry is to record information of therapy reality of metastatic or locally advanced Renal Cell Carcinoma by office-based medical oncologists in Germany.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with metastatic or locally advanced Renal Cell Carcinoma requiring therapy * Start of first palliative therapy within 1 year before enrollment of patient to registry; since enrollment of 1000 Patients: start of first palliative therapy within 4 weeks before enrollment Exclusion Criteria: \-

What they're measuring

Documentation of therapies

Timeframe: 9 years, 3 years per patient

Trial details

NCT IDNCT00610012

SponsoriOMEDICO AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-05-15

View on ClinicalTrials.gov More Renal Cell Carcinoma trials